Kristen Pierce - May 30, 2025 Form 4 Insider Report for CERO THERAPEUTICS HOLDINGS, INC. (CERO)

Role
Chief Development Officer
Signature
/s/ Andrew Kucharchuk, Attorney-in-Fact
Stock symbol
CERO
Transactions as of
May 30, 2025
Transactions value $
$0
Form type
4
Date filed
6/2/2025, 05:01 PM
Previous filing
Oct 2, 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Pierce Kristen Chief Development Officer CERO THERAPEUTICS HOLDINGS, INC., 201 HASKINS WAY, SUITE 230, SOUTH SAN FRANCISCO /s/ Andrew Kucharchuk, Attorney-in-Fact 2025-06-02 0002039649

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CERO Stock Option (Right to Buy) Award $0 +155K $0.00 155K May 30, 2025 Common Stock 155K $0.45 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option shall vest in equal monthly installments through June 4, 2027.